HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 HUTCHMED Limited today announced that, Inmagene Biopharmaceuticals has exercised options to license two drug candidates.
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
PureTech Health plc: PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia Prescription Drug User Fee Act (PDUFA) action date is September 26, 2024 If approved, KarXT would represent the first new pharmacological approach to treat.
Many Republican presidential candidates and members of Congress have called for U.S. military intervention to stop the flow of fentanyl from Mexico. The Onion asked conservatives why the United States should invade Mexico, and this is what they said.